Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 119
- Evidence Id
- 119
- Core Evidence Id
- 119
- Source Clinical Trial Id
- 114
- Herb2 Clinical Trial Id
- HBCT000114
- Nct Id
- NCT00914329
- Title
- Gelsemium Sempervirens in Anticipatory Anxiety
- Status
- Completed
- Phase
- Phase 3
- Study Result
- No
- Study Condition
- Anxiety
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Gelsemium Sempervirens|DRUG: Gelsemium Sempervirens|DRUG: Placebo
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Quadruple
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult
- Enrollment
- 180
- Outcome Measure
- Anxiety level evaluated by the STAI-E, in absolute value and et difference with basal state, according to the treatment received by the volunteers (Gelsemium sempervirens 5CH, 15CH or placebo), day 0
- Sponsor Collaborator
- University Hospital, Grenoble|BOIRON
- Funded By
- OTHER
- Location
- Clinical Research Center, Grenoble, 38043, France
- Other Id
- DCIC 08 20
- Start Date
- 2009-06
- Primary Completion Date
- 2010-04
- Completion Date
- 2010-05
- First Posted
- 2009-06-05
- Results First Posted
- Last Update Posted
- 2010-06-03
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT00914329
- Title Cn
- Title En
- Gelsemium Sempervirens in Anticipatory Anxiety
- Bilingual Status
- semi_complete